Cargando…
The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer’s Disease—Review of Literature and Interesting Images
Amyloid imaging using positron emission tomography (PET) has an emerging role in the management of Alzheimer’s disease (AD). The basis of this imaging is grounded on the fact that the hallmark of AD is the histological detection of beta amyloid plaques (Aβ) at post mortem autopsy. Currently, there a...
Autores principales: | Suppiah, Subapriya, Didier, Mellanie-Anne, Vinjamuri, Sobhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627350/ https://www.ncbi.nlm.nih.gov/pubmed/31242587 http://dx.doi.org/10.3390/diagnostics9020065 |
Ejemplares similares
-
Correlation between Standardized Uptake Value of (68)Ga-DOTA-NOC Positron Emission Tomography/Computed Tomography and Pathological Classification of Neuroendocrine Tumors
por: Kaewput, Chalermrat, et al.
Publicado: (2018) -
FAPI PET/CT Imaging—An Updated Review
por: Chandekar, Kunal Ramesh, et al.
Publicado: (2023) -
Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?
por: Suppiah, Subapriya, et al.
Publicado: (2017) -
A Review on the Usage of Bone Single-Photon Emission Computed Tomography/Computed Tomography in Detecting Skeletal Metastases in the Post-COVID-19 Era: Is it Time to Ditch Planar and Single-Photon Emission Computed Tomography only Gamma Camera Systems?
por: Suppiah, Subapriya, et al.
Publicado: (2023) -
Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015)